Clinical Trial Update: A Clinical Study to Evaluate Efficacy and Safety of Fimasartan/Hydrochlorothiazide Combination-therapy [Phase 3]

View source ↗

Summary

A Phase 3 trial evaluating the efficacy and safety of a fixed-dose combination of fimasartan and hydrochlorothiazide in essential hypertension has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Essential Hypertension

Drugs mentioned

• Fimasartan (fimasartan)
• HYDROCHLOROTHIAZIDE (hydrochlorothiazide)

Snippet

Sponsor: Boryung Pharmaceutical Co., Ltd | Conditions: Essential Hypertension | Phase 3 | Status: COMPLETED